Atlas Trials

Patients With Brain Metastases From HER2-positive Breast Cancer

Clinical trial NCT02135159 · COMPLETED

Trial details

NCT number
NCT02135159
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HER2-positive Breast Cancer
Start date
2014-02-01
Primary completion
2017-02-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.